https://doi.org/10.4081/reumatismo.2019.1041
Acquired Haemophilia A. Which is the best therapeutic choice in older adults? Single center study of 4 cases
Submitted: 9 July 2017
Accepted: 17 May 2018
Published: 1 April 2019
Accepted: 17 May 2018
Abstract Views: 1288
PDF: 952
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Acquired haemophilia A (AHA) is a rare bleeding disorder due to autoantibodies directed against coagulation factor VIII. The treatment is based on recombinant activated factor VII and activated prothrombin complex concentrate. However, mainly in older patients, severe thrombotic complications have been reported. Here we report the different therapeutic approaches in 4 cases of elderly patients with AHA and co-morbidities.
How to Cite
Mauro, E., Garlatti Costa, E., Zanier, A., Maset, M., Ermacora, A., Ghersetti, M., & Casarin, P. (2019). Acquired Haemophilia A. Which is the best therapeutic choice in older adults? Single center study of 4 cases. Reumatismo, 71(1), 37–41. https://doi.org/10.4081/reumatismo.2019.1041
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- L. Bazzichi, C. Giacomelli, A. Rossi, F. Sernissi, P. Scarpellini, A. Consensi, S. Bombardieri, Fibromyalgia and sexual problems , Reumatismo: Vol. 64 No. 4 (2012)
- L. Cantarini, D. Rigante, M.G. Brizi, G.D. Sebastiani, O.M. Lucherini, M. Galeazzi, B. Frediani, The laboratory approach in the diagnosis of systemic autoinflammatory diseases , Reumatismo: Vol. 63 No. 2 (2011)
- N. Maruotti, A. Corrado, F.P. Cantatore, Osteoporosis and rheumatic diseases , Reumatismo: Vol. 66 No. 2 (2014)
- M. Taraborelli, F. Inverardi, M. Fredi, A. Ceribelli, I. Cavazzana, A. Tincani, F. Franceschini, Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? , Reumatismo: Vol. 64 No. 5 (2012)
- F. Salaffi, A. Ciapetti, M. Carotti, The sources of pain in osteoarthritis: a pathophysiological review , Reumatismo: Vol. 66 No. 1 (2014)
- R. Talotta, F. Atzeni, A. Batticciotto, D. Ventura, P. Sarzi-Puttini, Possible relationship between certolizumab pegol and arrhythmias: report of two cases , Reumatismo: Vol. 68 No. 2 (2016)
- F. Atzeni, L. Boccassini, M. Di Franco, A. Alciati, A. Marsico, M. Cazzola, G. Cassisi, P. Sarzi-Puttini, Chronic widespread pain in spondyloarthritis , Reumatismo: Vol. 66 No. 1 (2014)
- F. Cacciapaglia, M.G. Anelli, D. Rizzo, E. Morelli, C. Scioscia, D. Mazzotta, F. Iannone, G. Lapadula, Influence of TNF-α inhibition on oxidative stress of rheumatoid arthritis patients , Reumatismo: Vol. 67 No. 3 (2015)
- Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee, COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with? , Reumatismo: Vol. 72 No. 3 (2020)
- M. Ferrito, G. Cincinelli, M. Manara, R. Di Taranto, E.G. Favalli, R. Caporali, Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients , Reumatismo: Vol. 75 No. 2 (2023)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
You may also start an advanced similarity search for this article.
